If you invest in a pre-FDA medical device and expect the company to get FDA approval without any delays you are completely delusional. I have worked for a company that has brought about 50 new devices to market through either full blown FDA or 510k, and almost every time there is some BS delay becauase the FDA isn't like a private company that gives a shit. Maybe Titan has a bunch of fluff in the timeline to shelter investors from these delays, wich would be really smart of them. In my company, one delay on one product isn't a big deal because we have so many other devices to sell, but a delay for a company with essentially one product could be viewed as a bigger deal. It sounds like where they lack in a field presence, they have an enourmous amount of resources being applied where they need it: development and pre-FDA. Ximedica has so many resources to throw at this process that it would be almost unbelievable if they coudn't get FDA, like what the hell were these idiots doing for the last two + years and when did they know. I'm betting on Titan big and feel like they are poised to get to market and there will be a big pay off for all of us early investors. If it is a buyout, which I am supporting at the right price, then they won't need a huge amount of market/field hires, but it will need to be timed with FDA otherwise they have approval but no way to sell the robot! I think they will hire a small team to get this launched and then lets see what happens. Even if they get bought out this team will need to be included as someone will need to be trained on how to sell this robot and then will train the rest of the larger team that works for a surgical company like JNJ or a Medtronic. Go Titan!!
Market Data 
Markets 
AI
